{"name":"Emmecell","slug":"emmecell","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOanB4U0dPa09fT2dXNHBWLWVlMl9EWlJGaTZrOV85dzRrNUhhb1hxcHJQaHRqaXB3UnZxZjl5YjBMeFB2ZGxzWlczNWVWRXU4SGFNdlFIa2NqeFg2OUt5VklSUjAzS1JfU2JuQTRuMlgtOXhkYWZMbmdtcFNMdi0zRHp5RlFnUWNRdTljVy1uejVaOFYtWTc3N1hwbUhab3pPcHBEUjYxaWdkUHV2NEFpSjFmMGNNcm5JS2c?oc=5","date":"2026-01-26","type":"pipeline","source":"Eyes On Eyecare","summary":"Leadership watch: Emmecell, ABO, Outlook, and Heidelberg make changes - Eyes On Eyecare","headline":"Leadership watch: Emmecell, ABO, Outlook, and Heidelberg make changes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOeXFiejNDalNWU0M0R09UUVBMOVY2dE5VZ0xGRFNodWdtODI1VlFEbm9HcFV3dC01bC1Yd1o0LXZiblhzVktHa0FUVWJMb2VBZHNYVFJLUDZqV1pybjNQV2lhaDBoV0w4ZktpTmkwRXJsLVlObURxWFZJbXJnUUE3MVJJV1ljYWx5UnNJ?oc=5","date":"2026-01-19","type":"pipeline","source":"Contract Pharma","summary":"Emmecell Appoints Ramin Valian as CEO - Contract Pharma","headline":"Emmecell Appoints Ramin Valian as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxONnozaUVFMjE3UVN4bDdwZmlZbjV4VDRnc1YzSDNPaVdISlliS1MyYzZrdXk5S2puOXYzbjd3a3ByUW9OZjFBRHMzNnhpMGN4QmVaY3hYa1ZJWjlHUG5FT21RZHVJQUxKcUgzckhTT19aRWx4bHFuYzdvdTZFVmNaS0ppS0FUTFlET2c?oc=5","date":"2026-01-16","type":"pipeline","source":"Yahoo Finance","summary":"Emmecell Appoints Ramin Valian as Chief Executive Officer to Advance Magnetic Cell Delivery Platform - Yahoo Finance","headline":"Emmecell Appoints Ramin Valian as Chief Executive Officer to Advance Magnetic Cell Delivery Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxPOUVfdGdCVTV4Y1p6M0lhMGFXalp2Y0ZuT0JqSlhtdjkwQWxsdW4yRTNBQnU3bnRnZ1lwNXJLX1R4VFVNWXl1cHdDTndkUGpkOFMyczkta0dqR2FJU2JWNjFIemYzSklmMzJGLVV5OFlIcWV4NXpOVDhBV004Y3V0QnBVRGdmS2Mxc1V1VWhlN3A0eUxWSWRRVG11QmxOcDl5UEJBTl8yY2JXc24tSFdjRGdFTUpCQUdjbGM4NkVwXy1md3NsUTZtalF5bF9id0o3QXoxNldlU00xNXdKRUMxX2tvRXdmUEFtdTNQME9hU25qTXRxeW1SN1V2MnRlejJETGU3UlUwaVdPeWVYVXVScw?oc=5","date":"2026-01-12","type":"regulatory","source":"PR Newswire UK","summary":"Persistent Corneal Edema Market to Show Impressive Growth at a CAGR of 21.8% During the Forecast Period (2025-2034) | DelveInsight - PR Newswire UK","headline":"Persistent Corneal Edema Market to Show Impressive Growth at a CAGR of 21.8% During the Forecast Period (2025-2034) | De","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNWFQ5aHNsdWF6dC13eHRNVGd4WWwwME1kR2tOeUEyZDEzbG9aVDRtS09ZeGZqRURNVjZabWdIUGhxbUpsc01RWHEzdTJ2QXZ5X2Q1X0lSNUZCcE5zRlhrc2R0R0N3VkZPREU3MWNvaERkc0NnQWgySjgzMDUxUlgxbGMwR3pNUGlKNW5PY1h1QWhkQlB0NWZCWnl3SkxsMnpIWDJ5a1RDSFd0RVQxNS03TDNOMFV0LUkt?oc=5","date":"2024-05-06","type":"regulatory","source":"Eyes On Eyecare","summary":"Cell therapy dosing concludes for Emmecell's corneal edema trial - Eyes On Eyecare","headline":"Cell therapy dosing concludes for Emmecell's corneal edema trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNSmxrZldFdjZzX1pVSGZDT0FnOGJ6aHY3NFJXTDNGek53Y3gtOFJlZ1FTRUw1R0cxOWJGRHVlZkY2M1hLajJCenRySHRnUGtDakpsWUZaS2ZlX0tuN09PaUc2blc1akQwSmdkSjkwS25BWmNEYUVzZXpjVlhDelFSNnhPR2lQc1BFN0RfZTR5emx3VGxQQUczcEVBbE95WXRubG1IRGNsek9vaVhRU0lGWEF1LS02eVptbE43XzMxaXR0NGNfWmFNYg?oc=5","date":"2020-09-22","type":"regulatory","source":"Fierce Biotech","summary":"Emmecell exits stealth mode as FDA greenlights clinical trials of cornea cell therapy - Fierce Biotech","headline":"Emmecell exits stealth mode as FDA greenlights clinical trials of cornea cell therapy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}